ScoreCardiology
Bleeding risk in atrial fibrillation (ATRIA)
Estimates the annual risk of major haemorrhage in patients with atrial fibrillation on warfarin.
Updated 31 October 2026
When to use it
Non-valvular atrial fibrillation when oral anticoagulation is considered or used, to identify bleeding risk factors.
What it needs
- Anaemia (Hb < 13 g/dL men, < 12 g/dL women)
- Severe renal disease (eGFR < 30 mL/min or dialysis)
- Age ≥ 75 years
- Prior haemorrhage
- Diagnosed hypertension
The points for each answer and the automatic total are in the app.
How to interpret it
| Result | Interpretation |
|---|---|
| ≤ 3 | Low risk (0–3): ≈ 0.8 % major bleeds/year |
| 4 | Intermediate risk (4): ≈ 2.6 %/year |
| ≥ 5 | High risk (5–10): ≈ 5.8 %/year |
Practical tip
Derived in warfarin-treated patients (ATRIA cohort); its performance with direct oral anticoagulants is less studied.
2 more practical tips in the app.
Reference
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
